News
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, will announce new clinical findings for ANKTIVA® ...
This small branch played a big role in advancing evidence-based genetic testing, and its loss diminishes US leadership in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback